18 – 22 NOV 2025
Suntec | Singapore

  • 00D
  • 00H
  • 00M
  • 00S

Navigating the IBD Galaxy: Conversations about Advanced Treatments

Synopsis

TBC

Agenda

Chairperson: TBC

1300-1310

Welcome and Introduction

1310-1330

Real-World Experience with Targeted IL-23 Inhibition
TBC

1330-1350

Should IL-23 inhibitors be used earlier in the IBD treatment algorithm?
TBC

1350-1400

SC Induction vs IV: Does the route really matter?
TBC

1400-1420

Panel Discussion: With IL-23s, how can we break the therapeutic ceiling?
TBC
 

1420-1425

Conclusion and Closing Remarks
TBC

Share

Key dates

Program enquiries

Program Manager
c/o MCI Asia Pacific